This is an aggregated industry headline. Read the full story at FierceBiotech →
Moderna's flu candidate sails through FDA advisory committee in unanimous votes
As Moderna reshapes itself in the wake of the pandemic, the company on Thursday passed a key milestone in its bid to expand the reach of its mRNA platform to the massive influenza vaccination market.
By FierceBiotech
· Jun 19, 2026
· via FierceBiotech
Image: FierceBiotech
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Before Aurobindo can complete its acquisition of Pennsylvania generics specialist Lannet, it will have to dive…
The WeekBriefing
The company will steer R&D toward other pipeline priorities after updated results for its approved combo fell …
The WeekSTAT News ↗
Disability researchers across the country worry about their jobs, and the future of their institutions, as a d…